Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice Chovi-Trull, Megias-Vericat, Santiago Bonanad Boix, Saturnino Haya Guaita, Ana Rosa Cid Haro, Marta Aguilar Rodriguez, Andres

Utilization of emicizumab in the treatment of a case of acquired haemophilia A María Ángeles Ocaña Gómez, Jorge Esquivel Negrín, Mario Ríos De Paz, María Dolores De Dios García

PEG-Interferon-α ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study Javier Milara, Maria Outeda-Macias, Ma Dolores Aumente-rubio, Patricio Más-Serrano, Azucena Aldaz, Ma Victoria Calvo, Ma Sergia García-Simón, Marisa Martin-Barbero, Núria Padullés-Zamora, Juan Antonio-Schoenenberger, Marianne Saavedra-Aldrich, Enrique Tévar-Alfonso, Ana Saval, Alfonso Pastor-Clerigues, Marta García, Luis Margusino-Framiñan, Jose Luis Montero-Alvarez, Esperanza Merino, Jose Ignacio Herrero, Mónica Beunza, Pablo Conesa-Zamora, Alvaro Gimenez-Manzorro, Dolors Comas-Sugrañes, Manuel Cano-Marron, Elena Jiménez-Mutiloa, Pilar Díaz-Ruíz, Julio Cortijo